• Users Online: 451
  • Print this page
  • Email this page
Year : 2020  |  Volume : 16  |  Issue : 1  |  Page : 27-29

A rare case of disseminated histoplasmosis with oral manifestations in a rheumatoid arthritis patient treated with rituximab: Diagnostic and management challenges – A review

Division of Rheumatology and Clinical Immunology, Medanta - The Medicity, Gurugram, Haryana, India

Correspondence Address:
Dr. Shruti Bajad
Room No. 13, 4th Floor, Medanta - The Medicity, Gurugram, Haryana
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/AMJM.AMJM_5_20

Rights and Permissions

Disseminated histoplasmosis happens to be a rare complication that rheumatologists come across in their clinical practice. Biologics, mainly tumor necrosis factor blockers, have been mentioned as one of the causative factors in invasive histoplasmosis, and there are few case reports to support that. However, rituximab use has not been reported with histoplasmosis infection frequently. The association of such novel biologic agents with serious infections such as histoplasmosis needs further exploration as timely management and intervention can be life-saving for the patient. We report about a 69-year-old female, diagnosed with rheumatoid arthritis, who was treated with rituximab and subsequently developed disseminated histoplasmosis. She was successfully managed with antifungals. Here, we discuss the latest evidence-based treatment modalities for such patients with special reference to rheumatoid patients on biologic therapy.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded154    
    Comments [Add]    

Recommend this journal